share_log

参天製薬:2025年3月期 第2四半期(中間期)決算短信〔IFRS〕(連結)

Santen Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [IFRS] (consolidated)

JPX ·  Nov 7 01:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more